Kyle Rodda, Financial Market Analyst at Capital.com, provides an overview of the "GRANOLAS" stocks in Europe (which comprises GSK, Roche, ASML, Nestle, Novartis, Novo Nordisk, L’Oreal, LVMH, AstraZeneca, SAP and Sanofi) and their common traits; whether they have performed in the past year against the backdrop of a sluggish European economy; and how they stack up against the "Magnificent 7" group of stocks.
Presented by Ryan Huang
Podcast edited by Emaad Akhtar (eakhtar@sph.com.sg)

The Final Breakfast Show: Ryan and Audrey turn the tables
15:24

Breakfast Quiz: Goodbye! We take a walk down memory lane with Ryan
13:32

Morning Shot: Why Cyberattacks Are Getting Smarter And What SMEs Are Missing
10:56